Envestnet Asset Management Inc. lessened its stake in Celestica Inc. (NYSE:CLS - Free Report) TSE: CLS by 12.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 131,804 shares of the technology company's stock after selling 19,382 shares during the quarter. Envestnet Asset Management Inc. owned 0.11% of Celestica worth $12,163,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Independent Advisor Alliance lifted its holdings in Celestica by 0.3% in the 4th quarter. Independent Advisor Alliance now owns 29,588 shares of the technology company's stock valued at $2,731,000 after purchasing an additional 79 shares in the last quarter. Jones Financial Companies Lllp raised its position in Celestica by 4.6% in the fourth quarter. Jones Financial Companies Lllp now owns 2,034 shares of the technology company's stock valued at $188,000 after purchasing an additional 89 shares during the period. Pinpoint Asset Management Ltd lifted its position in Celestica by 109.6% during the 4th quarter. Pinpoint Asset Management Ltd now owns 348 shares of the technology company's stock worth $32,000 after acquiring an additional 182 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Celestica by 43.6% in the fourth quarter. UMB Bank n.a. now owns 949 shares of the technology company's stock valued at $88,000 after purchasing an additional 288 shares during the period. Finally, Peregrine Capital Management LLC acquired a new stake in shares of Celestica during the fourth quarter valued at about $30,000. 67.38% of the stock is currently owned by institutional investors and hedge funds.
Celestica Trading Up 4.4 %
Shares of NYSE:CLS traded up $3.56 during midday trading on Friday, reaching $84.12. The company had a trading volume of 5,273,486 shares, compared to its average volume of 3,102,287. The company has a fifty day simple moving average of $94.54 and a two-hundred day simple moving average of $90.66. The firm has a market cap of $9.75 billion, a price-to-earnings ratio of 22.49 and a beta of 2.09. Celestica Inc. has a 1-year low of $40.25 and a 1-year high of $144.27. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.87 and a current ratio of 1.47.
Insider Buying and Selling at Celestica
In other news, insider Alok K. Agrawal sold 6,826 shares of the stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $133.92, for a total value of $914,137.92. Following the completion of the sale, the insider now owns 9,224 shares in the company, valued at $1,235,278.08. This represents a 42.53 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Robert Mionis sold 441,325 shares of Celestica stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $122.28, for a total value of $53,965,221.00. Following the transaction, the chief executive officer now owns 531,417 shares in the company, valued at $64,981,670.76. This represents a 45.37 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 934,381 shares of company stock valued at $116,673,769. 1.00% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on CLS shares. Barclays raised their price target on shares of Celestica from $139.00 to $157.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. JPMorgan Chase & Co. cut their price target on Celestica from $166.00 to $105.00 and set an "overweight" rating on the stock in a report on Thursday. TD Securities boosted their target price on shares of Celestica from $70.00 to $107.00 and gave the company a "buy" rating in a research note on Tuesday, January 28th. Stifel Nicolaus increased their price target on Celestica from $140.00 to $150.00 and gave the stock a "buy" rating in a research note on Wednesday, February 19th. Finally, CIBC dropped their target price on Celestica from $150.00 to $120.00 and set an "outperformer" rating on the stock in a report on Tuesday. Two investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $103.25.
Check Out Our Latest Research Report on CLS
About Celestica
(
Free Report)
Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
See Also

Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.